The "genome landscape" study showed by RNA sequencing on a cohort of 200 newly diagnosed AML patients that a significant proportion of these patients, mainly M4 and M5 subtypes of the French American British (FAB) classification, over-expressed transcripts of S100A8 and S100A9 [31]. This evidence concerns the gene S100A9 and acute myeloid leukemia.